Cargando…
Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
BACKGROUND: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colono...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239110/ https://www.ncbi.nlm.nih.gov/pubmed/30519113 http://dx.doi.org/10.2147/CLEP.S181204 |
_version_ | 1783371505159110656 |
---|---|
author | Mikkelsen, Ellen M Thomsen, Mette Kielsholm Tybjerg, Julie Friis-Hansen, Lennart Andersen, Berit Jørgensen, Jens Christian Riis Baatrup, Gunnar Njor, Sisse H Mehnert, Frank Rasmussen, Morten |
author_facet | Mikkelsen, Ellen M Thomsen, Mette Kielsholm Tybjerg, Julie Friis-Hansen, Lennart Andersen, Berit Jørgensen, Jens Christian Riis Baatrup, Gunnar Njor, Sisse H Mehnert, Frank Rasmussen, Morten |
author_sort | Mikkelsen, Ellen M |
collection | PubMed |
description | BACKGROUND: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colonoscopy. However, the validity of these data is unknown, and the incidence of complications is potentially underreported. OBJECTIVE: To evaluate the validity of the colonoscopy complications registered in the DCCSD by using medical records as the reference. Further, to evaluate the incidence of complications leading to hospital contact. METHODS: Among 14,671 individuals with a positive iFOBT result and a colonoscopy procedure performed from March 3, 2014 to December 31, 2014, we selected 295 individuals for medical record review. We calculated sensitivity as the proportion of true complications registered in the DCCSD out of all complications found in the medical records, and the positive predictive value (PPV) as the number of true complications in the DCCSD out of all DCCSD-registered complications. On the basis of the medical record data, we calculated the incidence proportion of hospital-registered complications overall and by subtype. RESULTS: In total, we reviewed 286 records and found 102 individuals with at least one complication. The sensitivity of the DCCSD for any complication was 29.4% (95% CI: 20.8–39.3) and the PPV was 88.2% (95% CI: 72.6–96.7). On the basis of the medical record data, the incidence proportion of any complication after colonoscopy was 0.70% (95% CI: 0.57–0.84) and that of perforation or lesion was 0.10% (95% CI: 0.06–0.17); bleeding, 0.41% (95% CI: 0.31–0.53); post-polypectomy syndrome, 0.16% (95% CI: 0.10–0.24); and other medical complications, 0.04 (95% CI: 0.02–0.09). CONCLUSION: The DCCSD has low sensitivity for complications, and improvements in data registration are warranted. The incidence proportion of any hospital-treated post-colonoscopy complication was 0.70% in 2014, which was the first year of the Danish national CRC screening program. This is within the range of complications reported by other studies. |
format | Online Article Text |
id | pubmed-6239110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62391102018-12-05 Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program Mikkelsen, Ellen M Thomsen, Mette Kielsholm Tybjerg, Julie Friis-Hansen, Lennart Andersen, Berit Jørgensen, Jens Christian Riis Baatrup, Gunnar Njor, Sisse H Mehnert, Frank Rasmussen, Morten Clin Epidemiol Original Research BACKGROUND: The Danish national screening program for colorectal cancer (CRC) consists of an immunochemical fecal occult blood test (iFOBT) followed by colonoscopy. The Danish Colorectal Cancer Screening Database (DCCSD) records data on the incidence of hospital-registered complications after colonoscopy. However, the validity of these data is unknown, and the incidence of complications is potentially underreported. OBJECTIVE: To evaluate the validity of the colonoscopy complications registered in the DCCSD by using medical records as the reference. Further, to evaluate the incidence of complications leading to hospital contact. METHODS: Among 14,671 individuals with a positive iFOBT result and a colonoscopy procedure performed from March 3, 2014 to December 31, 2014, we selected 295 individuals for medical record review. We calculated sensitivity as the proportion of true complications registered in the DCCSD out of all complications found in the medical records, and the positive predictive value (PPV) as the number of true complications in the DCCSD out of all DCCSD-registered complications. On the basis of the medical record data, we calculated the incidence proportion of hospital-registered complications overall and by subtype. RESULTS: In total, we reviewed 286 records and found 102 individuals with at least one complication. The sensitivity of the DCCSD for any complication was 29.4% (95% CI: 20.8–39.3) and the PPV was 88.2% (95% CI: 72.6–96.7). On the basis of the medical record data, the incidence proportion of any complication after colonoscopy was 0.70% (95% CI: 0.57–0.84) and that of perforation or lesion was 0.10% (95% CI: 0.06–0.17); bleeding, 0.41% (95% CI: 0.31–0.53); post-polypectomy syndrome, 0.16% (95% CI: 0.10–0.24); and other medical complications, 0.04 (95% CI: 0.02–0.09). CONCLUSION: The DCCSD has low sensitivity for complications, and improvements in data registration are warranted. The incidence proportion of any hospital-treated post-colonoscopy complication was 0.70% in 2014, which was the first year of the Danish national CRC screening program. This is within the range of complications reported by other studies. Dove Medical Press 2018-11-13 /pmc/articles/PMC6239110/ /pubmed/30519113 http://dx.doi.org/10.2147/CLEP.S181204 Text en © 2018 Mikkelsen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Mikkelsen, Ellen M Thomsen, Mette Kielsholm Tybjerg, Julie Friis-Hansen, Lennart Andersen, Berit Jørgensen, Jens Christian Riis Baatrup, Gunnar Njor, Sisse H Mehnert, Frank Rasmussen, Morten Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
title | Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
title_full | Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
title_fullStr | Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
title_full_unstemmed | Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
title_short | Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
title_sort | colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239110/ https://www.ncbi.nlm.nih.gov/pubmed/30519113 http://dx.doi.org/10.2147/CLEP.S181204 |
work_keys_str_mv | AT mikkelsenellenm colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT thomsenmettekielsholm colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT tybjergjulie colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT friishansenlennart colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT andersenberit colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT jørgensenjenschristianriis colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT baatrupgunnar colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT njorsisseh colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT mehnertfrank colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram AT rasmussenmorten colonoscopyrelatedcomplicationsinanationwideimmunochemicalfecaloccultbloodtestbasedcolorectalcancerscreeningprogram |